Familial Mediterranean Fever

Understanding a Genetic Inflammatory Disorder

WHY DOES THIS MATTER?

About 1 in 200 to 1 in 1,000 people in Mediterranean populations have FMF. While that might sound rare, it means thousands of people worldwide are affected. Understanding FMF matters because:

• Early diagnosis prevents complications: Untreated FMF can lead to kidney and liverA large organ that produces bile, detoxifies blood, and stores nutrients. damage from chronic inflammation and depositionThe process of bone matrix formation by osteoblasts. of proteinsLarge molecules made of amino acids with various functions in the body. called amyloid.
• Simple treatment exists: A medication called colchicine prevents most attacks.
• It explains mysterious symptoms: Many patients spend years being told “it’s all in your head” or “that doesn’t matter” before diagnosis.
• Genetic awareness helps families: If one person has FMF, family members can be tested.

THE GENETIC MYSTERY

The MEFV Gene: Your Body’s Inflammation Control

The gene responsible for FMF is called MEFV (MEditerranean FeVer). This gene is located on chromosome 16 and contains instructions for making a protein called pyrin.

💡 Think of pyrin like a fire extinguisher: When your immune cellsThe basic structural and functional units of life. detect an infection, they start an inflammatory fire to fight it. Pyrin’s job is to regulate that fire—making sure it doesn’t burn out of control. In FMF, the fire extinguisher is broken, so even tiny sparks turn into raging fires.

What Does Pyrin Actually Do?

Pyrin is a regulatory proteinA protein that controls gene expression by binding to DNA or other molecules. found primarily in white blood cells (neutrophils and monocytes). Its normal job is to:

• Monitor for danger signals: Pyrin watches for signsObjective clinical findings observable by a provider (e.g., edema, fever). of bacterial infection
• Regulate inflammation: When activated properly, it helps control the inflammatory response
• Prevent false alarms: Pyrin helps distinguish real threats from harmless stimuliChanges in the environment that are detected by sensory receptors.

When the MEFV gene is mutated, the pyrin protein doesn’t work correctly. It becomes hypersensitive—setting off inflammation alarms when there’s no real threat.

Common Mutations

Scientists have identified over 300 different mutations in the MEFV gene, but a few are particularly common:

The “Big Five” Mutations

• M694V: Most common and most severe; very frequent in Mediterranean populations
• V726A: Common in Armenian and Arab populations; moderate severity
• M694I: Seen across multiple ethnic groups; moderate to severe
• M680I: Common in Turkish populations; variable severity
• E148Q: Controversial—may be a mild mutationA change in DNA sequence that can affect gene function. or risk factor rather than disease-causing

The specific mutations a person has can affect:

• How early symptoms start (childhood vs. adulthood)
• How severe attacks are
• How well treatment works
• Risk of complications (like kidney damage)

Monocytes and Macrophages in FMF

The Body’s Clean-Up Crew Turns Into Arsonists

When we talk about inflammation in FMF, we often focus on neutrophils (the first responders), but monocytes and macrophages play a crucial supporting role in amplifying and sustaining the inflammatory attack, especially in the borderlands of the neruological organs (ex: meninges(singular: meninx) – Protective membranes surrounding the spinal cord and brain.)

---

What Are Monocytes and Macrophages?

Monocytes are white blood cells that patrol your bloodstream looking for trouble. When they detect inflammation (like the IL-1β signal released during an FMF attack), they:

1. Leave the bloodstream
2. Squeeze into inflamed tissue
3. Transform into macrophages

Macrophages are the tissue-resident version of monocytes. Think of monocytes as the patrol car, and macrophages as the officers who’ve gotten out and are actively working the scene.

Inside the Attack

What Happens in Your Body During an FMF Episode

From Trigger to Fever: The Inflammatory Cascade

Stina’s attacks seemed random, but they often followed stressful events—final exams, a bad cold, her menstrual period, or sometimes just physical exertion. Within hours of the trigger, she’d feel it starting: a vague sense of unease, then rapidly escalating fever and pain.

What’s actually happening inside her body during these attacks? Let’s follow the cascade from the cellular level to the full-body symptoms.

Step 1: The Trigger

FMF attacks don’t need an infection to start. Common triggers include:

• Stress: Physical or emotional stress
• Infections: Even minor viral colds can trigger an episode
• Menstruation: Hormonal changes in females
• Physical exertion: Intense exercise
• Cold exposure: Sudden temperature changes
• Surgery or trauma: Any tissue injury
• Unknown: Many attacks have no identifiable trigger

These triggers activate the immune system slightly—think of them as tiny sparks. In most people, the immune system would barely notice. But in FMF, the broken pyrin protein overreacts catastrophically.

Step 2: The Inflammasome Fires Up

Inside white blood cells, mutated pyrin assembles a molecular machine called an inflammasome. Think of this like a molecular alarm system that’s stuck on “MAXIMUM SENSITIVITY.”

💡 The Smoke Detector Analogy: Imagine a smoke detector so sensitive that it goes off when someone lights a birthday candle three rooms away. That’s what the pyrin inflammasome does in FMF—it detects minor cellular disturbances and triggers a five-alarm fire response.

What the Inflammasome Does

The pyrin inflammasome is a multi-protein complex that:

1. Assembles: Multiple pyrin proteins come together with adapter proteins (ASC) and an enzyme (caspase-1)
2. Activates caspase-1: This enzyme cleaves inactive pro-IL-1β into active IL-1β
3. Releases IL-1β: This cytokine is a powerful inflammatory signal molecule

In FMF, mutated pyrin forms inflammasomes too easily and releases massive amounts of IL-1β (interleukin-1 beta)—far more than the minor trigger would normally warrant.

Step 3: The Cytokine Storm

IL-1β is one of the body’s most powerful pro-inflammatory cytokines. Once released, it sets off a chain reaction:

Hour 0-2: Initial Release

White blood cells release huge amounts of IL-1β into surrounding tissues and bloodstream

Hour 2-6: Amplification

IL-1β activates other immune cells, which release additional inflammatory cytokines (IL-6, TNF-α). The signal spreads like wildfire through a dry California chaparrel.

Hour 6-12: Full-Blown Attack

Inflammatory mediators flood the bloodstream. Blood vessels dilate, white blood cells swarm to affected tissues (basically everything), fever spikes

Step 4: Serositis – Why It Hurts So Much

The most characteristic feature of FMF is inflammation of serosal membranes—the thin linings around your organs and body cavities.

What Are Serosal Membranes?

Serosal membranes are smooth, slippery linings that allow organs to move without friction:

• Peritoneum: Lines the abdominal cavityThe body cavity containing the stomach, intestines, liver, and other digestive organs. and covers abdominal organs
• Pleura: Lines the chest cavity and covers the lungs
• Pericardium: Surrounds the heart
• Synovium: Lines joint spaces

These membranes normally secrete a small amount of lubricating fluid. During FMF attacks, they become inflamed and produce excess fluid.

When IL-1β and other cytokines target these membranes:

• The membranes become red, swollen, and inflamed
• Fluid accumulates between the layers (called an effusion)
• The normally smooth surfaces become sticky and painful
• Every movement—breathing, walking, digesting—causes friction and pain

Step 5: Peak Symptoms (12-48 Hours)

At the height of an attack, Stina experiences:

• Fever: 100-104°F (38-40°C)—IL-1β acts on the hypothalamusA small but vital brain region controlling hormones, temperature, and autonomic functions. to raise body temperature
• Abdominal pain: Severe peritonitis mimics appendicitis or other surgical emergencies
• Chest pain: Pleurisy makes every breath painful
• Joint pain: Usually one large joint (knee, ankle) becomes hot, swollen, and immobile
• Fatigue: The inflammatory response consumes tremendous energyThe capacity to do work or cause change.

Step 6: Resolution (24-72 Hours)

Here’s the remarkable part: FMF attacks are self-limiting. Even without treatment, they resolve completely within 1-3 days. To confirm FMF, many people need testing during a flare up. This becomes complicated when testing is scheduled for weeks from the flare. I think of this like looking for unicorns.

Why Do Attacks Stop?

The body has natural anti-inflammatory mechanisms that eventually shut down the attack:

• Inflammasome depletion: Cells run out of inflammasome components
• Anti-inflammatory cytokines: IL-10 and other signals dampen inflammation
• Neutrophil exhaustion: The inflammatory cells become depleted
• Regulatory T cells: These immune cells help restore balance

The inflammation literally burns itself out, like a fire that runs out of fuel.

By 72 hours, the cytokine storm has passed. Fluid is reabsorbed. Serosal membranes heal. Stina feels completely normal again—until the next attack.

The Long-Term Danger: Amyloidosis

⚠️ Why Treatment Matters

While individual attacks resolve on their own, repeated inflammation over years causes a serious complication: amyloidosis.

During inflammation, the liver produces a protein called serum amyloid A (SAA). If inflammation is chronic, SAA can misfold and deposit in organs—especially the kidneys—as amyloid fibrils. Over time, these deposits damage kidney function and can lead to kidney failure.

This is why daily preventive treatment (colchicine) is crucial—it stops the attacks before amyloid can accumulate.

Key Takeaways

• FMF attacks start when triggers activate hypersensitive mutated pyrin
• The pyrin inflammasome releases massive IL-1β
• IL-1β triggers a cytokine cascade causing fever and widespread inflammation
• Serositis (inflammation of serosal membranes) causes the characteristic pain
• Attacks are self-limiting but can cause long-term kidney damage through amyloidosis

Up Next: Living with FMF

Now that we understand the mechanism, we’ll explore what FMF actually feels like day-to-day, what triggers attacks, and how it affects patients’ lives.

Living with FMF

Symptoms, Triggers, and the Daily Reality

Stina’s Story Continues

“The worst part isn’t the pain,” Stina says. “It’s the unpredictability. I might be fine for two months, then suddenly have three attacks in four weeks. I’ve missed job interviews, family weddings, vacation plans. I’ve had to leave work mid-shift doubled over in pain. People think I’m making it up because I look completely normal between attacks.”

“Before diagnosis, I spent thousands of dollars on ER visits. Every time, they’d run the same tests—CT scans, ultrasounds, blood work—finding nothing. Doctors would look at me like I was drug-seeking or mentally ill. One doctor told my parents it was all in my headRounded proximal end that fits into the acetabulum of the hip bone. and recommended a psychiatrist.”

“Getting diagnosed was like finally being believed.”

The Classic Symptom Triad

FMF attacks typically involve three main features occurring together:

Fever

95% of patients

High fever (100-104°F) that develops rapidly and resolves within 1-3 days. No infection present.

Serositis

90% of patients

Inflammation of membrane linings causing abdominal, chest, or joint pain. The hallmark of FMF.

Short Duration

100% of attacks

Attacks last 12-72 hours then resolve completely. Patients feel normal between episodes.

Common Symptoms During Attacks

Abdominal Pain (90% of Patients)

The most common symptom. Peritonitis causes severe abdominal pain that can mimic:

• Appendicitis: Right lower abdomen pain—many FMF patients have had unnecessary appendixA small, finger-like pouch attached to the cecum, thought to play a role in immune function. removal surgery
• Ovarian cysts or ectopic pregnancy: In females, often mistaken for gynecological emergencies
• Kidney stones: Severe, cramping pain
• Bowel obstruction: Patients may have nausea, vomiting, constipation

“I’ve had three surgeries because doctors were convinced it was appendicitis or an ovarian cyst. They’d open me up, find inflammation but no obvious cause, and send me home confused.” —Sarah, FMF patient

Chest Pain (40% of Patients)

Pleurisy (inflammation of the pleuraThe double-layered membrane surrounding the lungs and lining the thoracic cavity. around the lungs) causes:

• Sharp, stabbing chest pain that worsens with breathing
• Patients often breathe shallowly to avoid pain
• Can be mistaken for heart attack or pulmonary embolism
• Rarely, pericarditis (heart lining inflammation) occurs

Joint Pain (75% of Patients)

Typically affects ONE large joint per attack:

• Knee, ankle, or hip most common
• Joint becomes hot, swollen, red, and immobile
• Unlike rheumatoid arthritis, FMF arthritis doesn’t cause permanent joint damage. If imaging is done metween flares, no evidence would show.
• Resolves completely within a week

Less Common Symptoms

• Erysipelas-like erythemaRedness of the skin due to increased blood flow, often caused by heat, infection, or inflammation. (25%): Red, painful rash on the lower legs, especially around ankles
• Scrotal inflammation (5% males): Painful testicular swelling mimicking torsion or infection
• Muscle pain: Severe, prolonged muscle pain (protracted febrile myalgia), rare but debilitating
• Headache: Aseptic meningitis (inflammation of brain linings) in rare cases

What Triggers an Attack?

FMF attacks often seem random, but patients report certain triggers. However, the same trigger doesn’t always cause an attack, and many attacks have no identifiable trigger.

Common Triggers

• Physical stress: Intense exercise, prolonged standing, physical labor
• Emotional stress: Exams, work deadlines, family conflicts, anxiety
• Infections: Even minor colds or viral illnesses
• Menstruation: Many females have attacks during their period
• Temperature changes: Cold exposure or sudden weather changes
• Surgery or injury: Any tissue trauma
• Certain foods: Variable by person; some report cheese, alcohol, or specific foods
• Sleep deprivation: Inadequate rest
• Medication changes: Starting or stopping certain drugs

Attack Patterns: Highly Variable

No two FMF patients have identical attack patterns:

• Frequency: Some patients have 1-2 attacks per year; others have 1-2 per week
• Severity: Attacks can be mild (able to work through it) to severe (bedridden for days)
• Age of onset: 90% start before age 20, but some begin in adulthood
• Symptom pattern: Some always get abdominal pain; others cycle between abdomen, chest, and joints
• Warning signs: Some patients report a prodrome (vague unease, irritability) hours before; others have sudden onset

Impact on Quality of Life

FMF significantly affects patients’ lives:

• Work/School: Frequent absences can jeopardize employment or education
• Relationships: Unpredictability strains friendships and partnerships
• Mental health: Anxiety about when the next attack will strike; depression from chronic illness
• Healthcare costs: Before diagnosis, repeated ER visits and surgeries are expensive
• Social isolation: Patients may withdraw to avoid explaining their condition
• Misdiagnosis trauma: Being told symptoms are psychological is deeply damaging

Between Attacks: Completely Normal

This is what makes FMF so confusing. Between attacks, patients are:

• Pain-free and fully functional
• Physically indistinguishable from healthy people
• Able to exercise, work, and live normally
• Show normal blood work (no inflammation markers)

“The hardest part is being invisible. People see me at a party, looking fine, and forget that last week I was in the ER thinking I was dying. Even my family sometimes forgets and gets frustrated when I have to cancel plans.” —David, FMF patient

Key Takeaways

• FMF causes recurrent, self-limited attacks of fever and serositis
• Abdominal pain (90%) is most common, often mimicking surgical emergencies
• Attacks last 12-72 hours; patients are normal between episodes
• Triggers vary but include stress, infections, menstruation, and physical exertion
• Attack frequency and severity vary widely between patients
• FMF significantly impacts quality of life, work, and relationships

Up Next: Diagnosis and Management

In the final page, we’ll explore how FMF is diagnosed, what genetic testing reveals, how colchicine works, and what the long-term outlook is for patients.

Diagnosis & Management

Getting Answers and Finding Relief

Stina’s Turning Point

After 51 years of mysterious attacks, Stina finally saw a rheumatologist who asked one key question: “What’s your ethnic background?”

“Armenian on my father’s side,” Stina said.

The doctor’s eyes lit up. “Have you ever heard of Familial Mediterranean Fever?” Within two weeks, Stina had genetic testing results showing two MEFV mutations. She started colchicine that same day.

“I haven’t had a full attack in nine months,” Stina says. “For the first time since I was eight years old, I can plan my life.”

How is FMF Diagnosed?

FMF diagnosis relies on a combination of clinical features, family history, ethnic background, and genetic testing. There’s no single definitive test—it’s a clinical diagnosis supported by lab findings.

Clinical Diagnostic Criteria (Tel-Hashomer Criteria)

Major Criteria (need ≥2 for diagnosis):

• Recurrent febrile episodes with serositis (peritonitis, pleurisy, synovitis)
• AA amyloidosis without predisposing disease
• Favorable response to continuous colchicine treatment

Minor Criteria (supportive):

• Recurrent febrile episodes
• Erysipelas-like erythema (skinThe body’s largest organ, providing protection and regulation. rash)
• FMF in a first-degree relative

In practice, doctors suspect FMF when they see:

• Classic attack pattern: Recurrent fever + serositis lasting 12-72 hours
• Mediterranean ancestry: Turkish, Armenian, Arab, Jewish, Greek, Italian, etc.
• Age of onset: Usually childhood or adolescence
• Family history: Relatives with similar symptoms or known FMF
• Response to colchicine: Dramatic improvement on treatment is highly suggestive

Genetic Testing

Genetic testing sequences the MEFV gene looking for mutations. Results can be:

• Two mutations (homozygous or compound heterozygous): Confirms FMF diagnosis
• One mutation (heterozygous): May have mild FMF or be an asymptomatic carrier
• No mutations detected: Doesn’t rule out FMF—only 70% of clinical FMF cases have identifiable mutations with currentThe flow of electrical charge, as in ions moving across a neuron’s membrane. testing

Genetic Testing Limitations

About 30% of patients with classic FMF symptoms have negative genetic testing. This could be because:

• They have mutations in regions of the gene not covered by standard testing
• They have mutations in other genes that cause similar symptoms
• There are FMF-causing mutations not yet discovered

Bottom line: Negative genetic testing doesn’t rule out FMF if clinical symptoms are classic.

Laboratory Findings During Attacks

• Elevated inflammatory markers: High CRP, ESR, white blood cell count
• Elevated SAA (serum amyloid A): Chronic elevation indicates amyloidosis risk
• Normal findings between attacks: Labs normalize completely
• Urine protein: Check for proteinuria (sign of amyloid kidney damage)

Treatment: Colchicine Changes Everything

The discovery that colchicine prevents FMF attacks was revolutionary. This centuries-old gout medication is now the cornerstone of FMF treatment.

How Colchicine Works

Colchicine has multiple anti-inflammatory effects:

• Disrupts microtubules: Prevents white blood cells from migrating to sites of inflammation
• Inhibits inflammasome activation: Interferes with the assembly and function of the NLRP3 and pyrin inflammasomes
• Reduces IL-1β production: Decreases the inflammatory cytokine cascade
• Stabilizes cell membranes: Prevents excessive inflammatory mediator release

Colchicine Effectiveness

Treatment Success Rates

• 60-70% of patients: Complete attack prevention
• 95% of patients: Significant reduction in attack frequency and severity
• Nearly 100%: Prevention of amyloidosis when taken consistently

Dosing: Typical dose is 1.2-1.8 mg per day, taken as a single dose or divided doses. Must be taken daily, not just during attacks.

Side effects: Most common is diarrhea, which often improves over time. Rarely: muscle pain, nausea, abdominal cramping.

Critical: Colchicine Must Be Taken Daily

Many patients make the mistake of only taking colchicine during attacks. This doesn’t work! Colchicine prevents attacks but doesn’t treat them once they start. Daily, preventive use is essential to:

• Reduce attack frequency
• Prevent long-term amyloidosis
• Maintain stable inflammatory control

Alternative Treatments for Colchicine-Resistant FMF

About 5-10% of patients don’t respond adequately to colchicine. For these patients:

IL-1 Inhibitors

Medications: Anakinra, Canakinumab, Rilonacept

Mechanism: Block IL-1β directly, targeting the inflammatory cytokine

Effectiveness: Highly effective in colchicine-resistant cases

Drawback: Expensive; requires injections

Other Options

NSAIDs: For mild symptom relief during attacks

Immunosuppressants: Rarely used (e.g., azathioprine)

Note: These don’t prevent amyloidosis like colchicine does

Monitoring and Long-Term Management

FMF is a lifelong condition requiring ongoing care:

Regular Monitoring

• Every 6-12 months: Check kidney function (creatinine, urineThe liquid waste excreted by the kidneys. protein) to screen for amyloidosis
• During attacks: Check inflammatory markers (CRP, SAA) to assess disease activity
• Genetic counseling: Family planning discussions about inheritance risk
• Medication adherence: Ensure daily colchicine complianceThe ease with which the lungs expand and contract during breathing.

Special Considerations

• Pregnancy: Colchicine is generally considered safe; attacks may worsen or improve during pregnancy
• Surgery: Patients may need perioperative colchicine dose adjustments
• Infections: Vaccinations recommended (especially before immunosuppressive therapy)
• Lifestyle: No specific diet restrictions; stress management helpful

Prognosis: Living Well with FMF

With proper treatment, the outlook for FMF patients is excellent:

Modern FMF Prognosis

• Normal lifespan: With colchicine, life expectancy is normal
• Attack control: Most patients achieve excellent symptom control
• Amyloidosis prevention: Nearly 100% prevented with daily colchicine
• Quality of life: Most patients work, have families, and live normally
• No organ damage: Unlike many autoimmune diseases, FMF doesn’t cause progressive joint or organ damage (except amyloidosis if untreated)

Before colchicine (pre-1970s): FMF was devastating. Up to 60% of patients developed fatal kidney failure from amyloidosis.

After colchicine: This changed everything. FMF became a manageable chronic condition rather than a life-threatening disease.

Future Treatments

Research continues to improve FMF care:

• Gene therapy: Experimental approaches to correct the MEFV mutation
• Novel inflammasome inhibitors: Drugs specifically targeting pyrin or ASC
• Improved IL-1 blockers: Longer-acting formulations, oral medications
• Biomarkers: Better tests to predict who will develop amyloidosis
• Personalized medicine: Tailoring treatment based on specific mutations

Stina ‘s Message to Others

“If you have recurrent fevers and pain that doctors can’t explain, especially if you have Mediterranean ancestry, ask about FMF. Don’t let anyone tell you it’s all in your head.”

“Getting diagnosed was like getting my life back. I’m in graduate school now, planning a wedding, living normally. I take one pill a day. That’s it.”

“FMF doesn’t define me anymore. It’s just something I manage, like someone with asthmaA chronic condition characterized by airway inflammation, narrowing, and excessive mucus production, uses an inhaler. The difference between now and 15 years of mystery illness is night and day.”

🎓 You’ve Completed the FMF Learning Series!

You now understand:

✓ The patient experience and clinical presentation
✓ Genetic basis and inheritance patterns
✓ Cellular mechanisms and inflammasome pathology
✓ Symptoms, triggers, and quality of life impacts
✓ Diagnosis, treatment, and long-term prognosis

Key Takeaways – The Whole Picture

• FMF is a genetic autoinflammatory disorder caused by MEFV mutations
• Mutated pyrin triggers excessive IL-1β release, causing recurrent fever and serositis
• Diagnosis combines clinical criteria, ethnic background, and genetic testing
• Colchicine prevents attacks and amyloidosis in 95% of patients
• With treatment, patients live normal lives with normal lifespan
• Early diagnosis and consistent treatment are crucial to prevent complications